Preventing Influenza

38
Preventing Influenza “Prevent all the Disease You Can… Then Treat the Rest.” John D. Grabenstein

description

Preventing Influenza. “Prevent all the Disease You Can… Then Treat the Rest.” John D. Grabenstein. Seasonal Influenza Vaccines. Live Attenuated Influenza Vaccine (LAIV) (Flu Mist) Trivalent Inactivated Influenza Vaccine (TIV) (Fluzone, Fluviron, Fluarix, FluLaval, Afluria) - PowerPoint PPT Presentation

Transcript of Preventing Influenza

Page 1: Preventing Influenza

Preventing Influenza

“Prevent all the Disease You Can… Then Treat the Rest.”

John D. Grabenstein

Page 2: Preventing Influenza

Seasonal Influenza Vaccines

• Live Attenuated Influenza Vaccine (LAIV)(Flu Mist)

Trivalent Inactivated Influenza Vaccine (TIV)(Fluzone, Fluviron, Fluarix, FluLaval, Afluria)

-not all created equal

Page 3: Preventing Influenza

Target groups for Influenza Vaccination:

• Children age 6 months through 18 years old• Pregnant women• Caregivers• Healthcare workers• Elderly (>= 50 years old!) (ACIP not me!)• Nursing home patients• People with chronic pulmonary, cardiovascular, renal,

hepatic, immuno-supression, neuro-muscular, hematological or metabolic conditions.

• Any person who wishes to reduce the likelihood of becoming ill with or transmitting influenza to others.

Page 4: Preventing Influenza

Can the vaccine cause the Flu?• NO!

• TIV (the shots) cannot cause influenza because it is an inactivated vaccine.

• LAIV (the spray) cannot cause influenza because it cannot replicate in the temperature of the lower respiratory tract and dies at temps >38C. It only lives in the upper respiratory tract and and can cause “Influenza-like Illness”, but not the full blown disease.

Page 5: Preventing Influenza

Flu Mist (Live Attenuated Vaccine)

• Intranasal spray• Healthy, non-pregnant patients aged 2-49

years.• Not recommended within 7 days of taking care

of severely immunocompromised patients (Not recommended for HCW!)

• Dose: Total of 0.2ml (0.1ml in each nostril) for all patients aged 2-49 years

Page 6: Preventing Influenza

Children aged 2-8 years• If child aged 2- 8 years is receiving Influenza

vaccine for the first time, they should get a second dose at least 4 weeks after the initial dose within the same flu season.

• If child being vaccinated for the first time and receives only one dose-but does not return for the second dose that year, how many doses should that child receive the next year if still < 9 years old?

Page 7: Preventing Influenza

Start all over again!

• Administer 2 doses (at least 4 weeks apart) to children age 9 years or younger who are receiving influenza vaccine for the first time or who were vaccinated for the first time during the previous influenza season but only received 1 dose for that year.

ACIP (Advisory Committee on Immunization Practices) www.cdc.gov/vaccines/recs/acip

Page 8: Preventing Influenza

Who should NOT get LIVE vaccine?

• Allergic to eggs • Children less than 2 years of age• Children aged 2-4 years with asthma or wheezing• Children or adolescents on long-term aspirin therapy• Adults >= 50 years of age• Patients with chronic medical conditions• Pregnant women• Immunosuppressed/Immunodeficiency patient• Close contacts of these patients (some shedding of vaccine

virus occurs though transmission to others is rare.)• Previous history of Guillain-Barre syndrome

Page 9: Preventing Influenza

Inactivated Influenza Vaccine

• Age 6-35 mon (<3 years) = 0.25ml IM• (2 doses if first time, 1 month apart)

• Age 3 to < 9 years = 0.5ml IM• (2 doses if first time, 1 month apart)

• >= 9 years – adults = 0.5ml IM

Page 10: Preventing Influenza

Not All IM Vaccines Created Equal!

• Only Fluzone approved for all ages (6 months through adult)

• Fluvirin only approved for age >= 4 years through adult

• Afluria, Fluarix, FluLaval only for age • >=18 years to through adult

Page 11: Preventing Influenza

Who should not get TIV shots?

• Allergic to eggs

• Younger than 6 months old

Page 12: Preventing Influenza

How do I store my flu shots and Spray?

• Refrigerated at 2-8C (35-46F)

• Do not Freeze

Page 13: Preventing Influenza

H1N1 Vaccines

• Monovalent Vaccine A/Calif/07/2009(H1N1)• Made by the same manufacturers and by

same processes as the Trivalent Vaccine for seasonal influenza

• 250 million doses purchased by US Govt.• Producing about 20 million doses/week

Page 14: Preventing Influenza

Who gets H1N1 vaccine?

• Same indications as for seasonal influenza: (especially children > 6mon-24yrs, care providers to children, pregnant women, healthcare & emergency personnel, high risk conditions age 25-64yrs)

• Shots recommended for ages > 6mon• Spray recommended for ages > 2 years

Page 15: Preventing Influenza

H1N1 Quick Facts

• 98% of current circulating influenza cases

• Only 1% of cases are > 65 years old

• 4x risk of miscarriage if pregnant

Page 16: Preventing Influenza

Offering Other Vaccines?

• Pneumococcal 23-valent (Pneumovax)?• Streptococcus Pneumoniae• Not just for “pneumonia!”• More efficacious for bacteremia than

pneumonia (85-90% of serotypes)

Page 17: Preventing Influenza

Who Gets Pneumococcal Vaccine?

• Adults >= 65 years old• Age 19-64 who smoke or have asthma• Age 2-64 years with chronic illnesses:• -Cardiovascular, Pulmonary, Metabolic,

Immunosupression, Asplenia, Hepatic, Renal Disease…

ACIP recommendationswww.cdc.gov/vaccines/pubs/acip-list.htm

Page 18: Preventing Influenza

Dosing of Pneumococcal Vaccine

• 0.5ml IM (or SQ if you like the pain!)

• For ages >= 65 years – one time dose if 1st time receiving.

• For patients who got 1st dose PRIOR to age 65 years, should get a 2nd dose at age 65years or after, once 5 years have passed since 1st dose.

Page 19: Preventing Influenza

Can vaccines cause Guillain-Barre Syndrome?

• Immune Dysfunction where system attacks itself causing nerve damage.

• Can cause permanent nerve damage, paralysis or death.

• Rare but can happen with any infection.• Finding with some vaccines• BUT NOT at a higher rate in people being

vaccinated (no causual data found)• www.iom.edu

Page 20: Preventing Influenza

Statistically ?

• 1976-increased risk by 1 in 100,000 people who received swine flu vaccine

• (reason undetermined.)

• Recently: 1 in 1,000,000 vaccinated for seasonal flu may be at risk.

Page 21: Preventing Influenza

Institute of Medicine Safety Review

• Vaccines and autism• Thimerosal-containing vaccines and

neurodevelopmental disorders• Vaccines and Sudden Infant Death • Multiple vaccines and immune dysfunction• Influenza and neurological complications

Page 22: Preventing Influenza

www.iom.edu/CMS/2955.aspx

Look at executive summaries for information on each

Page 24: Preventing Influenza

Anti-Vaccine Groups

• National Vaccine Information Center• Alliance for Informed Choice in

Vaccination• Healthy Alternatives• People Advocating Vaccine Education• Vaccine Information Resource Center• Natural Immunity Information Network

Page 25: Preventing Influenza

Let’s “Go Vaccinate!”

• Patients make vaccine decisions based on:• Perceived susceptibility to the disease• Perceived seriousness of the disease• Perceived vaccine benefits• Perceived barriers (adverse reactions,

access, cost, time…)• Social Influence (friends, family, healthcare

workers…)

Page 26: Preventing Influenza

Misconceptions About Vaccines

• Diseases were disappearing before vaccines• No need to continue vaccinating• Vaccines cause harmful effects• People with disease were vaccinated• Hot lots of vaccine exist• Multiple vaccinations cause system overload• www.who.int/immunization_safety/aefi/

immunization_misconceptions

Page 27: Preventing Influenza

Adverse Events Following Influenza Vaccination

• TIV shots- Injection Site soreness• LAIV spray – mild form of natural disease• Syncope• Anaphylaxis

Page 28: Preventing Influenza

Treating Serious Adverse Events

• Allow for fainting without injury, plus access to hard surface if need CPR

• Epinephrine: 0.01mg/kg up to 0.5mg repeat every 5-10min

• Train staff and practice emergency plan• 911 (EMS) + epinephrine + CPR/BLS

Page 29: Preventing Influenza

True vs. False Allergy

• True Immediate hypersensitivity (typically within minutes)

• -itching, erythema, hives, urticaria: symptoms progressing toward anaphylaxis

• (shock, angioedema, severe bronchospasm, cardiovascular collapse)

• False allergy:• Fever, GI upset, neurologic events

Page 30: Preventing Influenza

Vasovagal Syncope

• Loss of consciousness• Extreme paleness• Sweating• Coldness of hands and feet• Nausea• Light-headedness• Dizziness• Visual disturbances

Page 31: Preventing Influenza

Frequency and timing

• 63% with =< 5 minutes post-vaccination• 8% within 15 minutes of vaccination• 35% reported in patients age 10-18 years• 71% reported in women• 14% of episodes result in hospitalization • (from injuries.)• Observe patient for suitable time after

vaccination. ACIP guidelines = 15 minutes

Page 32: Preventing Influenza

Screening and Consulting

• Have you ever reacted to a vaccine?• Do you have allergies to food, medications

vaccines? (Especially EGGS for influenza)• Do you have any medical conditions?• Do you or anyone in your care or

household have cancer, HIV, take prednisone?

• Hare you sick today?

Page 33: Preventing Influenza

Vaccine Information Statement

• Provide to each patient/caregiver• -updated annually• -provides an overview of benefits and risks

of vaccination • -required by law to provide patients with

most up to date version• www.cdc.gov/vis• www.immunize.org

Page 34: Preventing Influenza

Obtain Informed Consent

• Provides documentation• Provides record for patient (must be kept

for the patient’s lifetime)• Decreases liability/litigation

Page 35: Preventing Influenza

Documentation Requirements

• Name of patient• Date vaccine administered• Vaccine Manufacturer• Vaccine Lot Number• Name, address, title of person administering the

vaccine• Date printed on VIS• Date the VIS given to patient or representative

Page 36: Preventing Influenza

National Vaccine Injury Compensation Program

• Act passed in 1986• Excise tax levied each dose of vaccine sold in the

United States.• No fault insurance fund to cover vaccine-related

injuries.• If patient experiences an event listed, the patient

can be awarded damages through the VICP fund.• Must file a claim with the VICP, satisfy eligibility

requirements to receive compensation.

Page 37: Preventing Influenza

• The reward for work well done is the opportunity to do more.

• -Jonas Salk

Page 38: Preventing Influenza

VAERS

• Vaccine Adverse Events Reporting System

• Alerts manufacturers and CDC of adverse events

• www.vaers.hhs.gov • Or www.cdc.gov/vaccinesafety